Author:
Ogbede Joseph Uche,Giaever Guri,Nislow Corey
Abstract
AbstractUsing a validated yeast chemogenomic platform, we characterized the genome-wide effects of several pharmaceutical contaminants, including three N-nitrosamines (NDMA, NDEA and NMBA), two related compounds (DMF and 4NQO) and several of their metabolites. A collection of 4800 non-essential homozygous diploid yeast deletion strains were screened in parallel and the strain abundance was quantified by barcode sequencing. These data were used to rank deletion strains representing genes required for resistance to the compounds to delineate affected cellular pathways and to visualize the global cellular effects of these toxins in an easy-to-use searchable database. Our analysis of the N-nitrosamine screens uncovered genes (via their corresponding homozygous deletion mutants) involved in several evolutionarily conserved pathways, including: arginine biosynthesis, mitochondrial genome integrity, vacuolar protein sorting and DNA damage repair. To investigate why NDMA, NDEA and DMF caused fitness defects in strains lacking genes of the arginine pathway, we tested several N-nitrosamine metabolites (methylamine, ethylamine and formamide), and found they also affected arginine pathway mutants. Notably, each of these metabolites has the potential to produce ammonium ions during their biotransformation. We directly tested the role of ammonium ions in N-nitrosamine toxicity by treatment with ammonium sulfate and we found that ammonium sulfate also caused a growth defect in arginine pathway deletion strains. Formaldehyde, a metabolite produced from NDMA, methylamine and formamide, and which is known to cross-link free amines, perturbed deletion strains involved in chromatin remodeling and DNA repair pathways. Finally, co-administration of N-nitrosamines with ascorbic or ferulic acid did not relieve N-nitrosamine toxicity. In conclusion, we used parallel deletion mutant analysis to characterize the genes and pathways affected by exposure to N-nitrosamines and related compounds, and provide the data in an accessible, queryable database.
Funder
National Aeronautics and Space Administration
Canadian Research Chairs
Canadian Foundation for Innovation
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. McKinney, J. D. The molecular basis of chemical toxicity. Environ. Health Perspect. 61, 5–10 (1985).
2. Sartan recalls beg the question: Is compendial impurity testing enough? PharmTech https://www.pharmtech.com/view/sartan-recalls-beg-question-compendial-impurity-testing-enough.
3. Sörgel, F. et al. The contamination of valsartan and other sartans, part 1: New findings. J. Pharm. Biomed. Anal. 172, 395–405 (2019).
4. Magee, P. N. & Barnes, J. M. The production of malignant primary hepatic tumours in the rat by feeding dimethylnitrosamine. Br. J. Cancer 10, 114–122 (1956).
5. Scanlan, R. A. & Issenberg, P. N-nitrosamines in foods. C R C Crit. Rev. Food Technol. 5, 357–402 (1975).